Michael Doukas

2.7k total citations
66 papers, 1.1k citations indexed

About

Michael Doukas is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Doukas has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 21 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Doukas's work include Gastric Cancer Management and Outcomes (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Michael Doukas is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Michael Doukas collaborates with scholars based in Netherlands, United States and Greece. Michael Doukas's co-authors include Jan N.M. IJzermans, Marco J. Bruno, Maikel P. Peppelenbosch, Casper H.J. van Eijck, Julie Nonnekens, Cecile Beerens, Mustafa Suker, Dik C. van Gent, Melissa van Kranenburg and Marion de Jong and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Doukas

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Doukas Netherlands 18 414 393 301 184 174 66 1.1k
Tomohisa Furuhata Japan 19 529 1.3× 344 0.9× 167 0.6× 115 0.6× 321 1.8× 69 1.0k
Edward Greeno United States 19 491 1.2× 304 0.8× 202 0.7× 109 0.6× 205 1.2× 40 1.3k
Kanwal Raghav United States 19 568 1.4× 369 0.9× 349 1.2× 73 0.4× 221 1.3× 52 1.1k
Toru Yasutake Japan 23 685 1.7× 663 1.7× 379 1.3× 179 1.0× 391 2.2× 112 1.5k
Sandra J. Casak United States 18 455 1.1× 189 0.5× 215 0.7× 109 0.6× 171 1.0× 32 1.0k
Maria A. González-Carmona Germany 20 589 1.4× 214 0.5× 294 1.0× 249 1.4× 249 1.4× 79 1.3k
Irshad Soomro United Kingdom 19 297 0.7× 509 1.3× 643 2.1× 144 0.8× 262 1.5× 63 1.3k
Jae Ho Han South Korea 28 509 1.2× 402 1.0× 383 1.3× 132 0.7× 448 2.6× 88 1.5k
Laetitia Finzi France 13 150 0.4× 303 0.8× 183 0.6× 215 1.2× 238 1.4× 30 1.3k
Sameh Mikhail United States 22 747 1.8× 376 1.0× 415 1.4× 233 1.3× 270 1.6× 70 1.5k

Countries citing papers authored by Michael Doukas

Since Specialization
Citations

This map shows the geographic impact of Michael Doukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doukas more than expected).

Fields of papers citing papers by Michael Doukas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Doukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doukas. The network helps show where Michael Doukas may publish in the future.

Co-authorship network of co-authors of Michael Doukas

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Doukas. A scholar is included among the top collaborators of Michael Doukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Doukas. Michael Doukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buisman, Florian E., Rutger‐Jan Swijnenburg, Bianca Mostert, et al.. (2025). Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial. Journal of Clinical Oncology. 44(6). 455–465.
2.
Ven, Steffi E. M. van de, Bas L. Weusten, Lorenza Alvarez Herrero, et al.. (2024). Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett’s neoplasia: a nationwide cohort with pathology reassessment. Endoscopy. 56(8). 559–568. 3 indexed citations
3.
Driel, Lydi M.J.W. van, Bas Groot Koerkamp, Roy S. Dwarkasing, et al.. (2024). Endoscopic ultrasound with tissue acquisition of lymph nodes in patients with potentially resectable intrahepatic cholangiocarcinoma. SHILAP Revista de lepidopterología. 12(8). E998–E1005. 3 indexed citations
4.
Brouwer, Willem Pieter, et al.. (2024). Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis B. Journal of Hepatology. 82(4). 594–603. 3 indexed citations
5.
Fu, Siyu, Ruben Boers, Joachim Boers, et al.. (2023). Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma. Cancers. 15(19). 4784–4784. 8 indexed citations
6.
Janssen, Quisette P., Rutger Quispel, Marc G. Besselink, et al.. (2023). Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials. HPB. 25(10). 1161–1168. 3 indexed citations
7.
Starmans, Martijn P. A., Razvan L. Miclea, Valérie Vilgrain, et al.. (2023). Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics. Academic Radiology. 31(3). 870–879. 6 indexed citations
8.
Ramírez, Ricardo, Abhishek Aggarwal, Nicholas van Buuren, et al.. (2022). Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. Journal of Hepatology. 77(2). 332–343. 49 indexed citations
9.
Hassan, Muhammad, Carlie Sigel, Michael Doukas, et al.. (2021). EPIC-Survival: End-to-end Part Inferred Clustering for Survival Analysis, with Prognostic Stratification Boosting. 520–531. 3 indexed citations
10.
Schurink, Ivo J., Jubi E. de Haan, Jorke Willemse, et al.. (2021). A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion. Scientific Reports. 11(1). 23444–23444. 12 indexed citations
11.
Roessel, Stijn van, Eline C. Soer, Susan van Dieren, et al.. (2021). Axial slicing versus bivalving in the pathological examination of pancreatoduodenectomy specimens (APOLLO): a multicentre randomized controlled trial. HPB. 23(9). 1349–1359. 7 indexed citations
12.
Klompenhouwer, Anne J., David W.G. ten Cate, François E.J.A. Willemssen, et al.. (2019). The impact of imaging on the surgical management of biliary cystadenomas and cystadenocarcinomas; a systematic review. HPB. 21(10). 1257–1267. 14 indexed citations
13.
Klompenhouwer, Anne J., Roy S. Dwarkasing, Michael Doukas, et al.. (2019). Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome. HPB. 22(4). 622–629. 24 indexed citations
14.
Suker, Mustafa, Katharina Biermann, Casper H.J. van Eijck, & Michael Doukas. (2017). A Rare Tumor in the Common Bile Duct: A Case Report. 3(1). 10–12.
15.
Batistatou, Anna, Michael Doukas, John Panelos, et al.. (2007). Early gastric carcinoma with oncocytic features and extensive metastases. Pathology - Research and Practice. 203(7). 539–541. 4 indexed citations
16.
Bence, Aimee K., Michael Doukas, George A. Davis, et al.. (2004). Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects. Investigational New Drugs. 23(1). 39–49. 98 indexed citations
17.
Fleming, Donald R., et al.. (2000). Diagnostic and Clinical Implications of Lineage Fidelity in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation. Leukemia & lymphoma. 36(3-4). 309–313. 2 indexed citations
18.
Doukas, David J. & Michael Doukas. (1998). CONSIDERING ADVANCE DIRECTIVES FOR ONCOLOGY PATIENTS. Primary Care Clinics in Office Practice. 25(2). 423–431. 5 indexed citations
19.
Doukas, Michael, et al.. (1992). Identification and characterization of a nucleotide binding site on recombinant murine granulocyte/macrophage-colony stimulating factor. Bioconjugate Chemistry. 3(6). 484–492. 5 indexed citations
20.
Glassock, Richard J., Michael L. Tate, Carol B. Stelling, et al.. (1984). Recurrent Fractures, Hypophosphatemia, and Renal Insufficiency in an Elderly Woman. American Journal of Nephrology. 4(5). 329–335. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohisa Furuhata Breakdown of academic impact, for papers by Edward Greeno Breakdown of academic impact, for papers by Kanwal Raghav Breakdown of academic impact, for papers by Toru Yasutake Breakdown of academic impact, for papers by Sandra J. Casak Breakdown of academic impact, for papers by Maria A. González-Carmona Breakdown of academic impact, for papers by Irshad Soomro Breakdown of academic impact, for papers by Jae Ho Han Breakdown of academic impact, for papers by Laetitia Finzi Breakdown of academic impact, for papers by Sameh Mikhail
Rankless by CCL
2026